Filing Details

Accession Number:
0001127602-21-016241
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-11 13:00:00
Reporting Period:
2021-05-07
Accepted Time:
2021-05-11 16:44:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
97745 Thermo Fisher Scientific Inc. TMO Measuring & Controlling Devices, Nec (3829) 042209186
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1518973 Michel Lagarde 168 Third Avenue
Waltham MA 02451
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-07 29,100 $190.59 52,629 No 4 M Direct
Common Stock Disposition 2021-05-07 7,662 $468.71 44,967 No 4 S Direct
Common Stock Disposition 2021-05-07 5,566 $469.57 39,401 No 4 S Direct
Common Stock Disposition 2021-05-07 2,949 $470.47 36,452 No 4 S Direct
Common Stock Disposition 2021-05-07 1,100 $471.80 35,352 No 4 S Direct
Common Stock Disposition 2021-05-07 1,523 $472.79 33,829 No 4 S Direct
Common Stock Disposition 2021-05-07 2,578 $474.00 31,251 No 4 S Direct
Common Stock Disposition 2021-05-07 3,424 $475.02 27,827 No 4 S Direct
Common Stock Disposition 2021-05-07 3,802 $475.96 24,025 No 4 S Direct
Common Stock Disposition 2021-05-07 1,268 $476.80 22,757 No 4 S Direct
Common Stock Disposition 2021-05-07 4,162 $478.02 18,595 No 4 S Direct
Common Stock Disposition 2021-05-07 134 $478.78 18,461 No 4 S Direct
Common Stock Acquisiton 2021-05-10 21,600 $190.59 40,061 No 4 M Direct
Common Stock Disposition 2021-05-10 7,259 $463.24 32,802 No 4 S Direct
Common Stock Disposition 2021-05-10 3,734 $463.85 29,068 No 4 S Direct
Common Stock Disposition 2021-05-10 5,051 $465.07 24,017 No 4 S Direct
Common Stock Disposition 2021-05-10 5,103 $466.03 18,914 No 4 S Direct
Common Stock Disposition 2021-05-10 453 $467.16 18,461 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-05-07 29,100 $0.00 29,100 $190.59
Common Stock Stock Option (Right to Buy) Disposition 2021-05-10 21,600 $0.00 21,600 $190.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-03-07 2024-09-07 No 4 M Direct
14,900 2024-09-07 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $468.08 to $469.07, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), and (16) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $469.08 to $470.05, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $470.11 to $470.96, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $471.14 to $472.015, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $472.305 to $473.06, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $473.35 to $474.33, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $474.38 to $475.37, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $475.38 to $476.37, inclusive.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $476.43 to $477.37, inclusive.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $477.56 to $478.55, inclusive.
  11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $478.56 to $478.85, inclusive.
  12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $462.57 to $463.56, inclusive.
  13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $463.57 to $464.52, inclusive.
  14. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $464.59 to $465.54, inclusive.
  15. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $465.59 to $466.54, inclusive.
  16. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $466.99 to $467.37, inclusive.
  17. The option vests in four equal annual installments. One-quarter of the shares vested on September 7, 2018, 2019 and 2020, and the remaining one-quarter will vest on September 7, 2021.